Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.53% is 110% above its 1-year average of -5.39%, near the high end of its 1-year range (-28.18%–9.80%).
76.28% above its 12-month average of 0.30%.
Reported quarterly operating margin; no daily interpolation. Q1 FY2026 (2026-07-31): 4.51%.
OPERATING MARGIN
0.53%
OPERATING MARGIN AVG TTM
0.30%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+76.28%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 605 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
MiniMed Group, Inc. Common Stock
Market Cap
$5.56B
Operating Margin
0.53%
TTM Avg
0.30%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.65B
Operating Margin
11.92%
TTM Avg
0.31%
3Y Avg
-1.06%
5Y Avg
-68.44%
Market Cap
$5.71B
Operating Margin
-4722.13%
TTM Avg
-7394.69%
3Y Avg
-15105.91%
5Y Avg
-12109.07%
Market Cap
$5.35B
Operating Margin
29.60%
TTM Avg
36.63%
3Y Avg
34.40%
5Y Avg
32.73%
Market Cap
$5.22B
Operating Margin
-16191.40%
TTM Avg
-8762.23%
3Y Avg
-42994.83%
5Y Avg
-36872.33%
Market Cap
$5.84B
Operating Margin
-153.08%
TTM Avg
-197.00%
3Y Avg
-9782.25%
5Y Avg
-6521.50%
Market Cap
$5.95B
Operating Margin
17.61%
TTM Avg
2.04%
3Y Avg
3.68%
5Y Avg
13.44%
Market Cap
$5.07B
Operating Margin
12.75%
TTM Avg
11.82%
3Y Avg
10.28%
5Y Avg
7.77%
Market Cap
$5.09B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-174.05%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $5.56B | 0.53% | 0.30% | N/A | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.65B | 11.92% | 0.31% | -1.06% | -68.44% |
| CG Oncology Inc. (CGON)vs › | $5.71B | -4722.13% | -7394.69% | -15105.91% | -12109.07% |
| Doximity, Inc. (DOCS)vs › | $5.35B | 29.60% | 36.63% | 34.40% | 32.73% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.22B | -16191.40% | -8762.23% | -42994.83% | -36872.33% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.84B | -153.08% | -197.00% | -9782.25% | -6521.50% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 17.61% | 2.04% | 3.68% | 13.44% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 12.75% | 11.82% | 10.28% | 7.77% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.09B | 0.00% | 0.00% | 0.00% | -174.05% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.04B | 0.00% | 0.00% | -101.20% | -276.55% |
Gross Margin
53.9%
Operating Margin
0.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-07-31 | 4.51% |
| 2026-04-24 | 9.80% |
| 2026-01-31 | -11.77% |
| 2025-10-31 | -1.33% |
| 2025-04-30 | -28.18% |
